Completeness in the reporting of dermatologic adverse drug reactions associated with monoclonal antibody epidermal growth factor receptor inhibitors in phase II and III colorectal cancer clinical trials (Q37270042)
Jump to navigation
Jump to search
scientific article published on September 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Completeness in the reporting of dermatologic adverse drug reactions associated with monoclonal antibody epidermal growth factor receptor inhibitors in phase II and III colorectal cancer clinical trials |
scientific article published on September 2008 |
Statements
1 reference
Completeness in the reporting of dermatologic adverse drug reactions associated with monoclonal antibody epidermal growth factor receptor inhibitors in phase II and III colorectal cancer clinical trials (English)
1 reference
Kimberly A Bauer
1 reference
Scott Hammerman
1 reference
1 September 2008
1 reference
1 reference
Identifiers
1 reference